Inventor · disambiguated record
David Boothman
Also filed as: BOOTHMAN DAVID · BOOTHMAN DAVID A
14 granted patents·7 pending applications·153 citations·filing 1995–2022
91Inventor score
Top patents by PatentIndex Score
21 records- 0193US5763625ASynthesis and use of β-lapachone analogsWISCONSIN ALUMNI RES FOUND·Filed 1995·Granted Jun 9, 1998·71 cites·32 claims
- 0292US6890950B2Lapachone delivery systems, compositions and uses related theretoUNIV CASE WESTERN RESERVE·Filed 2003·Granted May 10, 2005·61 cites·20 claims
- 0390US9751970B2Block copolymer and micelle compositions and methods of use thereofUNIV TEXAS·Filed 2016·Granted Sep 5, 2017·10 cites·14 claims
- 0487US10017598B2Block copolymer and micelle compositions and methods of use thereofUNIV TEXAS·Filed 2017·Granted Jul 10, 2018·5 cites·16 claims
- 0582US9611266B2Compounds and anti-tumor NQO1 substratesUNIV ILLINOIS·Filed 2016·Granted Apr 4, 2017·3 cites·20 claims
- 0681US12091486B2Block copolymer and micelle compositions and methods of use thereofUNIV TEXAS·Filed 2022·Granted Sep 17, 2024·0 cites·13 claims
- 0773US11098150B2Block copolymer and micelle compositions and methods of use thereofUNIV TEXAS·Filed 2018·Granted Aug 24, 2021·0 cites·15 claims
- 0871US2020325265A1Novel block copolymer and micelle compositions and methods of use thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 0970US10272099B2Tumor-selective combination therapyUNIV TEXAS·Filed 2014·Granted Apr 30, 2019·2 cites·20 claims
- 1070US2020333350A1Novel block copolymer and micelle compositions and methods of use thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1169US9233960B2Compounds and anti-tumor NQO1 substratesHERGENROTHER PAUL J·Filed 2012·Granted Jan 12, 2016·1 cites·20 claims
- 1268US2020330383A1Novel block copolymer and micelle compositions and methods of use thereofTHE BOARD OF REGENTS OF THE UNIV OF TEXAS SYSTEMS·Filed 2020·Application pending·0 cites
- 1359US10285986B2Compounds and anti-tumor NQO1 substratesUNIV ILLINOIS·Filed 2018·Granted May 14, 2019·0 cites·25 claims
- 1456US9925180B2Compounds and anti-tumor NQO1 substratesUNIV ILLINOIS·Filed 2017·Granted Mar 27, 2018·0 cites·23 claims
- 1555US2005175668A1Lapachone delivery systems, compositions and uses related theretoUNIV CASE WESTERN RESERVE·Filed 2005·Application pending·0 cites
- 1648US2022160703A1Tumor-selective combination therapyUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1747US9631041B2PH-sensitive compositions for delivery of beta lapachone and methods of useGAO JINMING·Filed 2011·Granted Apr 25, 2017·0 cites·29 claims
- 1845US10576096B2Tumor-selective combination therapyUNIV TEXAS·Filed 2017·Granted Mar 3, 2020·0 cites·10 claims
- 1945US9469878B2Methods of treating cancer comprising targeting NQO1BOOTHMAN DAVID·Filed 2011·Granted Oct 18, 2016·0 cites·9 claims
- 2033US2017342503A1Xrn2 as a determinant of sensitivity to dna damageUNIV TEXAS·Filed 2017·Application pending·0 cites
- 2128US2018057888A1Kub5/hera as a determinant of sensitivity to dna damageUNIV TEXAS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Boothman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →